Bolt Biotherapeutics Inc.

NASDAQ: BOLT · Real-Time Price · USD
5.25
-0.19 (-3.49%)
At close: Aug 15, 2025, 3:01 PM

Bolt Biotherapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-6.47 -12.24 -11.31 -35.11
PEG Ratio
0.66 0.60 0.64 -0.87
PS Ratio
53.13 107.54 169.54 2.91K
PB Ratio
7.14 7.51 5.66 14.65
P/FCF Ratio
-6.66 -12.15 -12.38 -61.7
P/OCF Ratio
-6.67 -12.18 -12.7 -64.23
OCF/S Ratio
-7.97 -8.83 -13.35 -45.29
Debt / Equity Ratio
0.44 0.18 0.13 0.10
Quick Ratio
3.20 5.17 7.51 8.88
Current Ratio
3.20 5.17 7.47 8.87
Asset Turnover
0.08 0.05 0.03 0.00
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-1.1 -0.61 -0.5 -0.42
Return on Assets
-0.63 -0.43 -0.38 -0.34
Return on Invested Capital
-0.85 -0.54 -0.42 -0.34
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.72 0.76 0.15 -1.91
Net Profit Margin
-8.21 -8.79 -14.99 -82.85
Pretax Profit Margin
-8.21 -8.79 -15.38 -78.25
Operating Profit Margin
-9.5 -9.67 -15.77 -73.64
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-8.64 -9.44 -15.47 -72.69